Bibliographic Details
| Title: |
Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non-Small Cell Lung Cancer. |
| Authors: |
Parody-Rúa E; Research and Development Unit, Parc Sanitari Sant Joan de Déu, Sant Boi, Spain. Electronic address: e.parody@pssjd.org., Guevara-Cuellar CA; Faculty of Health Sciences, Universidad Icesi, Médico Institucional, Fundación Valle del Lili, Cali, Colombia. |
| Source: |
Value in health regional issues [Value Health Reg Issues] 2020 Dec; Vol. 23, pp. 93-98. Date of Electronic Publication: 2020 Nov 07. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: Elsevier Country of Publication: United States NLM ID: 101592642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2212-1102 (Electronic) Linking ISSN: 22121099 NLM ISO Abbreviation: Value Health Reg Issues Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
